Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-15

FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Archis Pharma LLC)

View source ↗

Summary

The FDA approved Archis Pharma LLC's supplemental application for mycophenolic acid (generic), indicating an approved modification to the marketed product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolic acid (mycophenolic acid)

Snippet

SUPPL AP for MYCOPHENOLIC ACID (MYCOPHENILIC ACID)